Blanchette, Sarah F.,Fitzgerald, Jonathan Basil,Gaddy, Daniel F.,Hendriks, Bart S.,Kalra, Ashish,Lee, Helen,Bayever, Eliel
申请号：
AU2016310476
公开号：
AU2016310476A1
申请日:
2016.08.19
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
Combination therapy regimens including liposomal irinotecan, oxaliplatin and 5-fluorouracil are useful in the treatment of pancreatic cancer, including treatment of patients diagnosed with previously untreated metastatic adenocarcinoma of the pancreas. The combination therapy can include the administration of liposomal irinotecan, oxaliplatin, leucovorin and 5-fluorouracil once every two weeks.
